Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers
Peter Horak(German Cancer Research Center), Klaus Schulze‐Osthoff(University of Tübingen), Thomas Kindler(German Cancer Research Center), Christoph E. Heilig(German Cancer Research Center), Laura Gieldon(Heidelberg University), Melanie Boerries(University of Freiburg), Karsten Spiekermann(German Cancer Research Center), Daniel B. Lipka(German Cancer Research Center), Bettina Meißburger(German Cancer Research Center), Gunnar Folprecht, Arne Jahn(VKTA), Roland Penzel(Heidelberg University), Daniela Richter(Krankenhaus Dresden-Friedrichstadt), Katrin Pfütze(German Cancer Research Center), Marinela Augustin(Nuremberg Hospital), Sebastian Bauer(Science for Life Laboratory), Barbara Hutter(Heidelberg University), Stephan Wolf(German Cancer Research Center), Matthias Kroiß, Lino Möhrmann(University Hospital Carl Gustav Carus), Ulrike Winter(German Cancer Research Center), Peter Hohenberger(University of Mannheim), Walter E. Aulitzky(Robert Bosch Hospital), Simon Kreutzfeldt(German Cancer Research Center), Richard F. Schlenk(German Cancer Research Center), Veronica Teleanu(German Cancer Research Center), Frederick Klauschen(Charité - Universitätsmedizin Berlin), Dorothea Hanf(Krankenhaus Dresden-Friedrichstadt), Christoph Heining(Krankenhaus Dresden-Friedrichstadt), Martina Fröhlich(Heidelberg University), Leo Ruhnke(Krankenhaus Dresden-Friedrichstadt), Ulrich Keilholz(German Cancer Research Center), Nikolas von Bubnoff(Universitäres Kinderwunschzentrum Lübeck), Andreas Möck(German Cancer Research Center), Ivo Buchhalter(German Cancer Research Center), Jens T. Siveke(German Cancer Research Center), Andreas Rump(VKTA), Volker Endris(Heidelberg University), Olaf Neumann(Heidelberg University), Peter Schirmacher(Heidelberg University), Christian Brandts(Goethe University Frankfurt), Jennifer Hüllein(Heidelberg University), Sebastian Uhrig(German Cancer Research Center), Philipp J. Jost(Medical University of Graz), Katja Beck(German Cancer Research Center), Anna Lena Illert(University of Freiburg), Michael Allgäuer(Heidelberg University), Michael Bitzer(University Children's Hospital Tübingen), Christina Geörg(German Cancer Research Center), Andreas Laßmann(Heidelberg University)
Cited by 282
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k